The effect of diabetes mellitus on outcomes of patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: data from a prospective double-blind clinical trial comparing treatment with linezolid versus vancomycin

Risk factors for and impact of methicillin-resistant Staphylococcus aureus nasal colonization in patients in a medical intensive care unit

(2013) Christina C. Chen et al.   AMERICAN JOURNAL OF INFECTION CONTROL

A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia

(2013) Andrew F Shorr et al.   BMC INFECTIOUS DISEASES

A Systematic Literature Review and Meta-Analysis of Factors Associated with Methicillin-Resistant Staphylococcus aureus Colonization at Time of Hospital or Intensive Care Unit Admission

(2013) James A. McKinnell et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

A nationwide study of comorbidity and risk of reinfection after Staphylococcus aureus bacteraemia

(2013) L. Wiese et al.   JOURNAL OF INFECTION

Staphylococcus aureus bloodstream infection: A pooled analysis of five prospective, observational studies

(2013) Achim J. Kaasch et al.   JOURNAL OF INFECTION

A Systematic Review of Risk Factors Associated with Surgical Site Infections among Surgical Patients

(2013) Ellen Korol et al.   PLoS One

Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis

(2013) Andre C Kalil et al.   BMJ Open

In Vivo Bioluminescence Imaging To Evaluate Systemic and Topical Antibiotics against Community-Acquired Methicillin-Resistant Staphylococcus aureus-Infected Skin Wounds in Mice

(2012) Y. Guo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study

(2012) R. G. Wunderink et al.   CLINICAL INFECTIOUS DISEASES

How Important is Methicillin-Resistant Staphylococcus aureus as a Cause of Community-Acquired Pneumonia and What is Best Antimicrobial Therapy?

(2012) Richard G. Wunderink   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Analysis of Pathogen and Host Factors Related to Clinical Outcomes in Patients with Hospital-Acquired Pneumonia Due to Methicillin-Resistant Staphylococcus aureus

(2012) N. Z. Haque et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Efficacy of linezolid compared to vancomycin in an experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated pigs*

(2011) Pilar Martinez-Olondris et al.   CRITICAL CARE MEDICINE

Pulmonary Function in Diabetes

(2010) Bram van den Borst et al.   CHEST

The role of diabetes mellitus in the treatment of skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: results from three randomized controlled trials

(2010) Benjamin A. Lipsky et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Pharmacodynamics of Vancomycin at Simulated Epithelial Lining Fluid Concentrations against Methicillin-Resistant Staphylococcus aureus (MRSA): Implications for Dosing in MRSA Pneumonia

(2009) Y. Harigaya et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Current Perspective of the HCAP Problem: Is It CAP or Is It HAP?

(2009) Eva Polverino et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE